Searching News Database: University of California
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 11 Jun 2026
Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer
Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer
HSMN NewsFeed - 19 Feb 2025
Biosion, Inc. Appoints Kedan Lin, Ph.D., as Chief Development Officer and President of Biosion US
Biosion, Inc. Appoints Kedan Lin, Ph.D., as Chief Development Officer and President of Biosion US
HSMN NewsFeed - 20 Jun 2024
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
HSMN NewsFeed - 7 Mar 2024
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
HSMN NewsFeed - 21 Feb 2024
Sira Medical Wins FDA Clearance for Augmented Reality Preoperative Surgical Planning Software
Sira Medical Wins FDA Clearance for Augmented Reality Preoperative Surgical Planning Software
HSMN NewsFeed - 8 Feb 2024
PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
HSMN NewsFeed - 27 Jun 2023
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
HSMN NewsFeed - 7 Mar 2023
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 8 Dec 2022
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
HSMN NewsFeed - 18 Oct 2022
Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board
Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board
HSMN NewsFeed - 9 Aug 2022
ImmPACT Bio Names Vikram Lamba as Chief Financial Officer and Head of Business Development
ImmPACT Bio Names Vikram Lamba as Chief Financial Officer and Head of Business Development
HSMN NewsFeed - 3 May 2022
UCI Health Adopts ViewRay(R) MRIdian(R) MRI-Guided Radiation Therapy System
UCI Health Adopts ViewRay(R) MRIdian(R) MRI-Guided Radiation Therapy System
HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
HSMN NewsFeed - 24 Nov 2021
BD Names Francesca DeMartino as Senior Vice President of Investor Relations
BD Names Francesca DeMartino as Senior Vice President of Investor Relations
HSMN NewsFeed - 9 Nov 2021
Industry Veteran Kameel Farag Joins Aspen Neuroscience as Chief Financial Officer
Industry Veteran Kameel Farag Joins Aspen Neuroscience as Chief Financial Officer
HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
HSMN NewsFeed - 2 Sep 2021
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
HSMN NewsFeed - 27 Jul 2021
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
HSMN NewsFeed - 1 Jun 2021
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
HSMN NewsFeed - 29 Mar 2021
Phoenix Molecular Designs Appoints Biotech Powerhouse, Michael Varney, Ph.D., to its Advisory Board
Phoenix Molecular Designs Appoints Biotech Powerhouse, Michael Varney, Ph.D., to its Advisory Board
HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 22 Jan 2021
Boston Scientific Receives FDA Approval For The Vercise Genus(TM) Deep Brain Stimulation System
Boston Scientific Receives FDA Approval For The Vercise Genus(TM) Deep Brain Stimulation System
HSMN NewsFeed - 23 Nov 2020
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
HSMN NewsFeed - 29 Jul 2020
Truvian Sciences Receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG(TM) Test
Truvian Sciences Receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG(TM) Test
HSMN NewsFeed - 18 Jun 2020
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
HSMN NewsFeed - 9 Jun 2020
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Acquist Therapeutics Announces New Appointments to its Board of Directors
HSMN NewsFeed - 24 Apr 2020
Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd(R)
Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd(R)
HSMN NewsFeed - 14 Feb 2020
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
HSMN NewsFeed - 3 Feb 2020
Truvian Sciences Appoints Shane Bowen, Ph.D. as Senior Vice President of Engineering
Truvian Sciences Appoints Shane Bowen, Ph.D. as Senior Vice President of Engineering
HSMN NewsFeed - 7 Jan 2020
IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer
IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 13 Nov 2019
Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
HSMN NewsFeed - 28 Mar 2019
Sciton Unveils New JOULE X Platfor(TM)m During ASLMS, Bringing Realtime Aesthetic Insights Into Your Hands
Sciton Unveils New JOULE X Platfor(TM)m During ASLMS, Bringing Realtime Aesthetic Insights Into Your Hands
HSMN NewsFeed - 31 Jan 2019
IGM Biosciences Appoints M. Kathleen Behrens, Ph.D., to Board of Directors
IGM Biosciences Appoints M. Kathleen Behrens, Ph.D., to Board of Directors
HSMN NewsFeed - 29 Jan 2019
Nanospectra Biosciences Names Michael Brawer, M.D. as Chief Medical Officer
Nanospectra Biosciences Names Michael Brawer, M.D. as Chief Medical Officer
HSMN NewsFeed - 4 Jan 2019
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
HSMN NewsFeed - 2 Jan 2019
LIGHTMED Corporation Founder and Executive Chairman Gary Lee Reassumes CEO Role
LIGHTMED Corporation Founder and Executive Chairman Gary Lee Reassumes CEO Role
HSMN NewsFeed - 5 Nov 2018
Biocept Announces New Executive Hires to its Sales and Marketing Organization
Biocept Announces New Executive Hires to its Sales and Marketing Organization
HSMN NewsFeed - 21 Aug 2018
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
HSMN NewsFeed - 16 Aug 2018
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
HSMN NewsFeed - 11 Jun 2018
IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors
IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors
HSMN NewsFeed - 3 May 2018
GigaGen Announces Appointment of Sheila M. Keating, Ph.D., as Director, Immunology
GigaGen Announces Appointment of Sheila M. Keating, Ph.D., as Director, Immunology
HSMN NewsFeed - 3 Apr 2018
Oncternal Therapeutics Further Strengthens Leadership with Additions to Board of Directors
Oncternal Therapeutics Further Strengthens Leadership with Additions to Board of Directors
HSMN NewsFeed - 22 Mar 2018
LIGHTMED Corporation Appoints Dennis Dowell as Director of Sales and Marketing for North America
LIGHTMED Corporation Appoints Dennis Dowell as Director of Sales and Marketing for North America
HSMN NewsFeed - 27 Dec 2017
Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
HSMN NewsFeed - 14 Dec 2017
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
HSMN NewsFeed - 3 Nov 2017
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
HSMN NewsFeed - 5 Oct 2017
IFM Therapeutics LLC Appoints William R. Roush as Executive Vice President of Chemistry
IFM Therapeutics LLC Appoints William R. Roush as Executive Vice President of Chemistry
HSMN NewsFeed - 26 Sep 2017
CTI BioPharma Appoints Laurent Fischer as New Chairman of the Board and Announces Management Promotions
CTI BioPharma Appoints Laurent Fischer as New Chairman of the Board and Announces Management Promotions
HSMN NewsFeed - 20 Sep 2017
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
HSMN NewsFeed - 7 Sep 2017
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
HSMN NewsFeed - 17 Jul 2017
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
HSMN NewsFeed - 7 Feb 2017
BlackThorn Therapeutics Names Biotech Industry Veteran Gregory Vontz as Chief Executive Officer
BlackThorn Therapeutics Names Biotech Industry Veteran Gregory Vontz as Chief Executive Officer
HSMN NewsFeed - 27 Jan 2017
Juno Therapeutics Appoints Corsee D. Sanders as Executive Vice President and Head of Development Operations
Juno Therapeutics Appoints Corsee D. Sanders as Executive Vice President and Head of Development Operations
HSMN NewsFeed - 13 Dec 2016
Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy
Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy
HSMN NewsFeed - 6 Dec 2016
Theresa LaVallee, Ph.D., Joins Celldex Therapeutics’ Senior Management Team
Theresa LaVallee, Ph.D., Joins Celldex Therapeutics’ Senior Management Team
HSMN NewsFeed - 22 Nov 2016
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
HSMN NewsFeed - 13 Oct 2016
Carl Zeiss Meditec Appoints Steven C. Schallhorn, MD as Chief Medical Officer
Carl Zeiss Meditec Appoints Steven C. Schallhorn, MD as Chief Medical Officer
HSMN NewsFeed - 12 Sep 2016
Regeneron Announces Election of Bonnie Bassler, Ph.D., and Huda Zoghbi, M.D., to Board of Directors
Regeneron Announces Election of Bonnie Bassler, Ph.D., and Huda Zoghbi, M.D., to Board of Directors
HSMN NewsFeed - 22 Aug 2016
Singlera Genomics Raises $20 Million In Series A Financing Led by Lilly Asia Ventures
Singlera Genomics Raises $20 Million In Series A Financing Led by Lilly Asia Ventures
HSMN NewsFeed - 8 Aug 2016
Inspyr Therapeutics Appoints Ronald Shazer, M.D., as Senior Vice President and Chief Medical Officer
Inspyr Therapeutics Appoints Ronald Shazer, M.D., as Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 8 Aug 2016
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
HSMN NewsFeed - 1 Aug 2016
Sorrento Therapeutics Announces the Appointment of Dr. Yue Alexander Wu to its Board of Directors
Sorrento Therapeutics Announces the Appointment of Dr. Yue Alexander Wu to its Board of Directors
HSMN NewsFeed - 28 Jul 2016
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
HSMN NewsFeed - 29 Jun 2016
Corvus Pharmaceuticals Names Jason V. Coloma to Newly Created Post of Chief Business Officer
Corvus Pharmaceuticals Names Jason V. Coloma to Newly Created Post of Chief Business Officer
HSMN NewsFeed - 5 May 2016
aTyr Pharma Appoints Grove Matsuoka as Senior Vice President, Product Programs and Planning
aTyr Pharma Appoints Grove Matsuoka as Senior Vice President, Product Programs and Planning
HSMN NewsFeed - 18 Mar 2016
ProNAi Therapeutics Appoints Jeffrey H. Cooper and Tran Nguyen to its Board of Directors
ProNAi Therapeutics Appoints Jeffrey H. Cooper and Tran Nguyen to its Board of Directors
HSMN NewsFeed - 8 Mar 2016
Arbutus Appoints Dr. Elizabeth Howard Executive Vice President and General Counsel
Arbutus Appoints Dr. Elizabeth Howard Executive Vice President and General Counsel
HSMN NewsFeed - 7 Mar 2016
Avita Medical Announces U.S. FDA Approval for Increase in Compassionate Use of ReCell(R) Patient Cases
Avita Medical Announces U.S. FDA Approval for Increase in Compassionate Use of ReCell(R) Patient Cases
HSMN NewsFeed - 29 Feb 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
HSMN NewsFeed - 10 Feb 2016
Imprimis Pharmaceuticals to Make a Lower Cost Compounded and Customizable Alternative to Thiola(R)
Imprimis Pharmaceuticals to Make a Lower Cost Compounded and Customizable Alternative to Thiola(R)
HSMN NewsFeed - 27 Jan 2016
BioPharmX Corporation Appoints Craig A. Barbarosh to its Board of Directors
BioPharmX Corporation Appoints Craig A. Barbarosh to its Board of Directors
HSMN NewsFeed - 26 Jan 2016
Varian Medical Systems Appoints Dr. Patrick Kupelian VP of Clinical Affairs
Varian Medical Systems Appoints Dr. Patrick Kupelian VP of Clinical Affairs
HSMN NewsFeed - 5 Jan 2016
Editas Medicine Expands Leadership Team with Key Organizational Appointments
Editas Medicine Expands Leadership Team with Key Organizational Appointments
HSMN NewsFeed - 14 Dec 2015
Stryker Introduces New Advanced Imaging Modalities To Minimally Invasive Surgery With The 1588 AIM Platform
Stryker Introduces New Advanced Imaging Modalities To Minimally Invasive Surgery With The 1588 AIM Platform
HSMN NewsFeed - 27 Oct 2015
Mirna Therapeutics Appoints Dr. Miguel Barbosa as Executive Vice President and Chief Scientific Officer
Mirna Therapeutics Appoints Dr. Miguel Barbosa as Executive Vice President and Chief Scientific Officer
HSMN NewsFeed - 22 Oct 2015
Eiger BioPharmaceuticals Appoints Thomas J. Dietz, Ph.D. to the Eiger Board of Directors
Eiger BioPharmaceuticals Appoints Thomas J. Dietz, Ph.D. to the Eiger Board of Directors
HSMN NewsFeed - 15 Oct 2015
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
HSMN NewsFeed - 10 Sep 2015
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
HSMN NewsFeed - 14 Jul 2015
New TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
New TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
HSMN NewsFeed - 6 Jul 2015
OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development
OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development
HSMN NewsFeed - 28 May 2015
Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer
Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer
HSMN NewsFeed - 8 May 2015
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development
HSMN NewsFeed - 14 Apr 2015
Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs
Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs
HSMN NewsFeed - 19 Feb 2015
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
HSMN NewsFeed - 9 Feb 2015
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
HSMN NewsFeed - 10 Sep 2014
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
HSMN NewsFeed - 3 Jun 2014
Leading UCLA Physician Dr. Ian Cook Joins NeuroSigma As Chief Medical Officer and Senior Vice President
Leading UCLA Physician Dr. Ian Cook Joins NeuroSigma As Chief Medical Officer and Senior Vice President
HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
HSMN NewsFeed - 12 May 2014
Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs
Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs
HSMN NewsFeed - 17 Apr 2014
Gamma Medica Creates Strategic Advisory Board Chaired by Veteran Health Technology Executive Robert Cascella
Gamma Medica Creates Strategic Advisory Board Chaired by Veteran Health Technology Executive Robert Cascella
HSMN NewsFeed - 16 Apr 2014
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
HSMN NewsFeed - 28 Mar 2014
NeuroSigma Expands Its Management Team with Two Former Amgen Finance Executives
NeuroSigma Expands Its Management Team with Two Former Amgen Finance Executives
HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
HSMN NewsFeed - 11 Feb 2014
Former Amgen Finance Executive Carl Adams Joins NeuroSigma As Vice President and Controller
Former Amgen Finance Executive Carl Adams Joins NeuroSigma As Vice President and Controller
HSMN NewsFeed - 7 Jan 2014
Cortice Biosciences Announces the Appointment of George Farmer, Ph.D. as Chief Executive Officer
Cortice Biosciences Announces the Appointment of George Farmer, Ph.D. as Chief Executive Officer
HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
HSMN NewsFeed - 28 Oct 2013
Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer
Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer
HSMN NewsFeed - 3 Oct 2013
Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
HSMN NewsFeed - 19 Sep 2013
Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies
Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies
HSMN NewsFeed - 16 Sep 2013
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
HSMN NewsFeed - 5 Jun 2013
Johnson & Johnson Innovation Announces Opening of the California Innovation Center
Johnson & Johnson Innovation Announces Opening of the California Innovation Center
HSMN NewsFeed - 28 May 2013
Kala Pharmaceuticals Appoints Charles McDermott as Executive Vice President of Business Development
Kala Pharmaceuticals Appoints Charles McDermott as Executive Vice President of Business Development
HSMN NewsFeed - 8 May 2013
Surgeons Implant Magnetic Growing Rods In Groundbreaking Treatment For Early-Onset Scoliosis
Surgeons Implant Magnetic Growing Rods In Groundbreaking Treatment For Early-Onset Scoliosis
HSMN NewsFeed - 7 May 2013
Corgenix Gains CE Mark for ReLASV(R) Antigen Rapid Test for Diagnosis of Lassa Fever
Corgenix Gains CE Mark for ReLASV(R) Antigen Rapid Test for Diagnosis of Lassa Fever
HSMN NewsFeed - 7 May 2013
ASTRO and AUA Issue Joint Guideline for Radiation Therapy After Prostatectomy
ASTRO and AUA Issue Joint Guideline for Radiation Therapy After Prostatectomy
HSMN NewsFeed - 1 May 2013
Ultragenyx Appoints Eric Yuen, MD as Chief Medical Officer and Senior Vice President
Ultragenyx Appoints Eric Yuen, MD as Chief Medical Officer and Senior Vice President
HSMN NewsFeed - 19 Apr 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
HSMN NewsFeed - 9 Apr 2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
HSMN NewsFeed - 13 Mar 2013
Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
HSMN NewsFeed - 6 Mar 2013
Study: Surefire Medical's Technology Improves Delivery Of Embolics In Cancer Treatment
Study: Surefire Medical's Technology Improves Delivery Of Embolics In Cancer Treatment
HSMN NewsFeed - 5 Mar 2013
Myriad's Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study
Myriad's Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study
HSMN NewsFeed - 28 Feb 2013
Auxogyn Appoints Women's Health Leader, Kathryn A. Tunstall, to Board of Directors
Auxogyn Appoints Women's Health Leader, Kathryn A. Tunstall, to Board of Directors
HSMN NewsFeed - 13 Feb 2013
Lpath Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
Lpath Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
HSMN NewsFeed - 4 Jan 2013
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
HSMN NewsFeed - 17 Dec 2012
CAS Medical Systems Names Dr. John Gamelin as Vice President of Research & Development
CAS Medical Systems Names Dr. John Gamelin as Vice President of Research & Development
HSMN NewsFeed - 3 Dec 2012
ImmunoCellular Therapeutics Appoints Andrew Gengos as Chief Executive Officer
ImmunoCellular Therapeutics Appoints Andrew Gengos as Chief Executive Officer
HSMN NewsFeed - 30 Oct 2012
Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
HSMN NewsFeed - 2 Oct 2012
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
HSMN NewsFeed - 28 Sep 2012
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
HSMN NewsFeed - 25 Sep 2012
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
HSMN NewsFeed - 31 Jul 2012
Benvenue Medical Completes Enrollment in KAST Study Evaluating Kiva(R) vs. Kyphoplasty
Benvenue Medical Completes Enrollment in KAST Study Evaluating Kiva(R) vs. Kyphoplasty
HSMN NewsFeed - 27 Jun 2012
Accuray Announces Installation of TomoTherapy(R) System at University of California, San Francisco
Accuray Announces Installation of TomoTherapy(R) System at University of California, San Francisco
HSMN NewsFeed - 14 Jun 2012
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
HSMN NewsFeed - 16 May 2012
NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
HSMN NewsFeed - 24 Apr 2012
LDR Announces FDA Clearance and Launch of the ROI-C(R) Lordotic Cervical Cage
LDR Announces FDA Clearance and Launch of the ROI-C(R) Lordotic Cervical Cage
HSMN NewsFeed - 2 Apr 2012
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
HSMN NewsFeed - 27 Mar 2012
Synta Announces Appointment of George Farmer, Ph.D., as Vice President, Corporate Development
Synta Announces Appointment of George Farmer, Ph.D., as Vice President, Corporate Development
HSMN NewsFeed - 27 Mar 2012
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
HSMN NewsFeed - 26 Mar 2012
A.P. Pharma Appoints Thomas Ottoboni, Ph.D. as Vice President of Pharmaceutical Development
A.P. Pharma Appoints Thomas Ottoboni, Ph.D. as Vice President of Pharmaceutical Development
HSMN NewsFeed - 15 Mar 2012
iCAD Launches Post-Market Study of Intra-Operative Radiation Therapy to Treat Early Stage Breast Cancer
iCAD Launches Post-Market Study of Intra-Operative Radiation Therapy to Treat Early Stage Breast Cancer
HSMN NewsFeed - 14 Mar 2012
KYTHERA Biopharmaceuticals Appoints Industry Veteran Elisabeth Sandoval as Chief Commercial Officer
KYTHERA Biopharmaceuticals Appoints Industry Veteran Elisabeth Sandoval as Chief Commercial Officer
HSMN NewsFeed - 30 Nov 2011
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
HSMN NewsFeed - 29 Nov 2011
InSite Vision Wins Patent Interference Litigation Against the University of California, San Francisco
InSite Vision Wins Patent Interference Litigation Against the University of California, San Francisco
HSMN NewsFeed - 9 Nov 2011
PharmAthene Appoints Linda L. Chang Senior Vice President, Chief Financial Officer
PharmAthene Appoints Linda L. Chang Senior Vice President, Chief Financial Officer
HSMN NewsFeed - 31 Oct 2011
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL(TM) For Postsurgical Pain Management
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL(TM) For Postsurgical Pain Management
HSMN NewsFeed - 17 Oct 2011
New Stent Provides Relief to Patients with Advanced Small Intestine Cancer
New Stent Provides Relief to Patients with Advanced Small Intestine Cancer
HSMN NewsFeed - 14 Oct 2011
EMKinetics Announces Start of Pivotal Trial for the TranStim(TM) Transdermal Neuromodulation System
EMKinetics Announces Start of Pivotal Trial for the TranStim(TM) Transdermal Neuromodulation System
HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
HSMN NewsFeed - 21 Jun 2011
Kurt May to Join International Stem Cell Corporation as Senior Vice President
Kurt May to Join International Stem Cell Corporation as Senior Vice President
HSMN NewsFeed - 17 Jun 2011
Seattle Genetics Announces Promotion of Eric Dobmeier to Chief Operating Officer
Seattle Genetics Announces Promotion of Eric Dobmeier to Chief Operating Officer
HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Northwest Biotherapeutics Announces Change and Expansion of Management Team
HSMN NewsFeed - 7 Jun 2011
Cyterix Pharmaceuticals Raises $9.2 Million in a Series A Venture Financing
Cyterix Pharmaceuticals Raises $9.2 Million in a Series A Venture Financing
HSMN NewsFeed - 18 May 2011
Molecular Response Appoints Kenna Anderes, PhD, as Senior Vice President of Translational Medicine
Molecular Response Appoints Kenna Anderes, PhD, as Senior Vice President of Translational Medicine
HSMN NewsFeed - 10 May 2011
Abbott's HUMIRA(R) (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study
Abbott's HUMIRA(R) (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study
HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Appoints Kathlene L. Powell Vice President, Quality Operations
Raptor Pharmaceutical Appoints Kathlene L. Powell Vice President, Quality Operations
HSMN NewsFeed - 4 Apr 2011
PERCIVIA LLC Appoints Amit D. Munshi, President and Chief Executive Officer
PERCIVIA LLC Appoints Amit D. Munshi, President and Chief Executive Officer
HSMN NewsFeed - 24 Mar 2011
Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
HSMN NewsFeed - 24 Mar 2011
Bausch & Lomb Appoints David Mordaunt, Ph.D. as Vice President, Development and Research, Surgical
Bausch & Lomb Appoints David Mordaunt, Ph.D. as Vice President, Development and Research, Surgical
HSMN NewsFeed - 8 Mar 2011
Stellar Biotechnologies Appoints Vice President, Business Development & Marketing
Stellar Biotechnologies Appoints Vice President, Business Development & Marketing
HSMN NewsFeed - 8 Mar 2011
Mazor Robotics' SpineAssist(R) Purchased by University of California, Irvine Medical Center
Mazor Robotics' SpineAssist(R) Purchased by University of California, Irvine Medical Center
HSMN NewsFeed - 23 Feb 2011
Genesis Biopharma Appoints L. Stephen Coles M.D., Ph.D. to Board of Directors
Genesis Biopharma Appoints L. Stephen Coles M.D., Ph.D. to Board of Directors
HSMN NewsFeed - 17 Feb 2011
Stemedica Receives Approval From UCSD to Initiate Ischemic Stroke Study With Adult Allogeneic Stem Cells
Stemedica Receives Approval From UCSD to Initiate Ischemic Stroke Study With Adult Allogeneic Stem Cells
HSMN NewsFeed - 3 Feb 2011
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
HSMN NewsFeed - 2 Dec 2010
Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Appointment
Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Appointment
HSMN NewsFeed - 16 Nov 2010
Affymax Names Herb Cross as Chief Accounting Officer and Vice President of Finance
Affymax Names Herb Cross as Chief Accounting Officer and Vice President of Finance
HSMN NewsFeed - 8 Nov 2010
ZIOPHARM Oncology Appoints Brian L. Hamilton, M.D., Ph.D., as Senior Vice President, Clinical Operations
ZIOPHARM Oncology Appoints Brian L. Hamilton, M.D., Ph.D., as Senior Vice President, Clinical Operations
HSMN NewsFeed - 12 Oct 2010
Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
HSMN NewsFeed - 5 Oct 2010
NKT Therapeutics Announces Hiring of Barbara Finck, M.D. as Chief Medical Officer
NKT Therapeutics Announces Hiring of Barbara Finck, M.D. as Chief Medical Officer
HSMN NewsFeed - 5 Oct 2010
Titan Medical Inc. Appoints Urology Expert Hiep Thieu Nguyen, M.D. to Its Medical Advisory Board
Titan Medical Inc. Appoints Urology Expert Hiep Thieu Nguyen, M.D. to Its Medical Advisory Board
HSMN NewsFeed - 5 Oct 2010
RHUCIN Clinical Trial Data Published in the Journal of Allergy and Clinical Immunology
RHUCIN Clinical Trial Data Published in the Journal of Allergy and Clinical Immunology
HSMN NewsFeed - 4 Oct 2010
DFine Announces FDA 510(k) Clearance of New Radiofrequency Ablation System for Metastatic Spinal Lesions
DFine Announces FDA 510(k) Clearance of New Radiofrequency Ablation System for Metastatic Spinal Lesions
HSMN NewsFeed - 25 Aug 2010
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
HSMN NewsFeed - 16 Aug 2010
Curaxis Pharmaceutical Corp Elects Dr. Bert A. Spilker to Board of Directors
Curaxis Pharmaceutical Corp Elects Dr. Bert A. Spilker to Board of Directors
HSMN NewsFeed - 6 Aug 2010
Medtronic Completes Enrollment in Clinical Study of Complete SE(R) (Self-Expanding) Vascular Stent
Medtronic Completes Enrollment in Clinical Study of Complete SE(R) (Self-Expanding) Vascular Stent
HSMN NewsFeed - 29 Jul 2010
Calistoga Pharmaceuticals Appoints Langdon L. Miller, M.D., Executive Vice President, Research & Development
Calistoga Pharmaceuticals Appoints Langdon L. Miller, M.D., Executive Vice President, Research & Development
HSMN NewsFeed - 21 Jul 2010
Concentric Medical Announces First Stroke Patients Treated With the Merci Retriever(R) in Japan
Concentric Medical Announces First Stroke Patients Treated With the Merci Retriever(R) in Japan
HSMN NewsFeed - 9 Jul 2010
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
HSMN NewsFeed - 22 Jun 2010
DexCom Names Steven R. Pacelli Chief Operating Officer; Jorge Valdes Chief Technical Officer
DexCom Names Steven R. Pacelli Chief Operating Officer; Jorge Valdes Chief Technical Officer
HSMN NewsFeed - 1 Jun 2010
Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
HSMN NewsFeed - 14 May 2010
Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery
Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery
HSMN NewsFeed - 13 May 2010
3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations
3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations
HSMN NewsFeed - 23 Apr 2010
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
HSMN NewsFeed - 14 Apr 2010
Hybridyne Imaging Technologies Receives FDA Clearance for New Medical Imaging System
Hybridyne Imaging Technologies Receives FDA Clearance for New Medical Imaging System
HSMN NewsFeed - 14 Apr 2010
Paul Westberg Joins Versartis as Senior Vice President, Business Development
Paul Westberg Joins Versartis as Senior Vice President, Business Development
HSMN NewsFeed - 6 Apr 2010
Cataract Treatment Gets More Precise With FDA Approval of Softec HD(TM) Lens
Cataract Treatment Gets More Precise With FDA Approval of Softec HD(TM) Lens
HSMN NewsFeed - 26 Mar 2010
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
HSMN NewsFeed - 16 Mar 2010
Organovo Names Marie Csete Executive Vice President of Research and Development
Organovo Names Marie Csete Executive Vice President of Research and Development
HSMN NewsFeed - 9 Mar 2010
FDA Clears GeNO LLC Investigational New Drug Application for Nitric Oxide Delivery System
FDA Clears GeNO LLC Investigational New Drug Application for Nitric Oxide Delivery System
HSMN NewsFeed - 8 Mar 2010
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
HSMN NewsFeed - 2 Mar 2010
Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer Recurrence
Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer Recurrence
HSMN NewsFeed - 23 Feb 2010
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
HSMN NewsFeed - 17 Feb 2010
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
HSMN NewsFeed - 17 Feb 2010
Otonomy Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
Otonomy Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
Additional items found! 500
Members Archive contains
500 additional stories matching:
University of California
(Password required)
University of California
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!